CatalystFDA/Bio

BEYONDSPRING INC. (BYSI) DISCUSSES FDA FAST TRACK DESIGNATION AND STRATEGIC TRANSACTION FOR PLINABULIN IN POST-ICI NON-SQUAMOUS NSCLC TRANSCRIPT - SEEKINGALPHA

FDA Fast Track designation and strategic transaction for plinabulin in post-ICI NSCLC.

What changed

FDA Fast Track designation and strategic transaction for plinabulin in post-ICI NSCLC.

Why it matters

FDA Fast Track designation and strategic transaction for plinabulin in post-ICI NSCLC. — impact context not separately stored; see What changed.

Sources